Sign in
4

Changes in Ownership

Cellectar Biosciences, Inc. Filed Acc 0001104659-23-125483

President and CEO acquired 40,596 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
CARUSO JAMES V President and CEO 2023-12-08 Grant or award +40,596 49,236 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
CARUSO JAMES V President and CEO 2023-06-23 Grant or award · Stock option (right to buy) +261,000 261,000 D: show line 2 in the form
Loading xslF345X05/tm2332764-1_4seq1.xml…